New progress in prevention of preeclampsia
10.3760/cma.j.cn431274-20200628-00876
- VernacularTitle:子痫前期的预防新进展
- Author:
Lin HUANG
1
;
Dunjin CHEN
;
Jingsi CHEN
Author Information
1. 广州医科大学附属第三医院 广州重症孕产妇救治中心 510150；广州医科大学附属第三医院 广东省产科重大疾病重点实验室 510150
- From:
Journal of Chinese Physician
2020;22(7):972-976
- CountryChina
- Language:Chinese
-
Abstract:
Preeclampsia is a common gestational disease, involves multisystem disorder and carries risks for both mother and baby. Low-dose aspirin is the most comprehensive among the prevention candidates. The 2019 ACOG recommends the use of low-dose aspirin after 12 weeks of gestation as prevention if the patient has one or more of high-risk factors. WHO recommends calcium supplementation as one of strategy for prevention of preeclampsia, especially for the pregnant women who are likely to be low serum calcium or low calcium intake. Other medicines, antioxidants or sodium restriction are lack of evidence even present controversy. This paper highlights the latest guidelines, research findings and other new advances in preeclampsia prevention.
